Investigating the effect of probiotics on menstrual disorders and anti-mullerin hormone levels in patients with polycystic syndrome type A and B

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251127068135N1

Enrollment

100

Registered

2026-05-02

Start date

2026-05-22

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: 50 people with polycystic ovary syndrome type A and B will be in the intervention group, who will take one FemiCare probiotic daily for 12 weeks,.After 12 weeks, the anti-Mullerian hor

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of PCOS based on established criteria (such as the Rotterdam criteria) AMH above 3.5

Exclusion criteria

Exclusion criteria: Other important medical conditions that affect hormone levels or gut microbiota Use of medications that affect hormonal levels or gut microbiota

Design outcomes

Primary

Measure	Time frame
Anti mullerian hurmon. Timepoint: 12weeks. Method of measurement: In-vitro quantitative measurement.	—

Secondary

Measure	Time frame
The sound is muffled. Timepoint: 12weeks. Method of measurement: Clinical examination.;Hormonal pattern hair loss. Timepoint: 12weeks. Method of measurement: Clinical examination.;Acne. Timepoint: 12weeks. Method of measurement: Clinical examination.;Breast reduction. Timepoint: 12weeks. Method of measurement: Clinical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Zahra Hashemi

Shahid Beheshti University of Medical Sciences

zahra.hash71@gmail.com+98 21 2303 1307

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026